Goldman Sachs’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-30,000
Closed -$1.85M 6836
2025
Q4
$1.85M Hold
30,000
﹤0.01% 4660
2025
Q3
$1.76M Hold
30,000
﹤0.01% 4588
2025
Q2
$1.75M Sell
30,000
-50,000
-63% -$2.83M ﹤0.01% 4279
2025
Q1
$3.97M Sell
80,000
-205,200
-72% -$10.5M ﹤0.01% 3577
2024
Q4
$12.8M Buy
+285,200
New +$13.5M ﹤0.01% 2564
2023
Q3
Sell
-30,300
Closed -$1.79M 5759
2023
Q2
$1.79M Buy
+30,300
New +$1.93M ﹤0.01% 3956
2018
Q4
Sell
-101,338
Closed -$5.85M 5536
2018
Q3
$5.85M Buy
101,338
+100,000
+7,474% +$5.54M ﹤0.01% 2867
2018
Q2
$73K Sell
1,338
-12,042
-90% -$597K ﹤0.01% 5277
2018
Q1
$632K Buy
+13,380
New +$670K ﹤0.01% 4342

Other funds holding NTR

Goldman Sachs's NTR Position: Q1 2026 in Review

Goldman Sachs increased its Nutrien (NTR) stake by 79% in Q1 2026, buying an estimated $69.9M and bringing the position to 2,227,573 shares worth $168M. The position accounts for 0.02% of the portfolio, ranked #758.

Goldman Sachs first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $201M in Q3 2025. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Goldman Sachs held 2,227,573 shares of Nutrien worth $168M as of Q1 2026.
  • Goldman Sachs bought 980,305 Nutrien shares in Q1 2026, an estimated $69.9M.
  • Nutrien made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #758 holding.
  • Goldman Sachs first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
  • Goldman Sachs's Nutrien position peaked at $201M in Q3 2025.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.